DUKE UNIVERSITY
Determinants of AAV Tropism
Determinants of AAV Tropism is a funding opportunity from DUKE UNIVERSITY, up to 680850, closing April 30, 2028.
Apr 30, 2028
(639d left)Overview
Abstract Adeno-associated virus (AAV)-based gene therapies have shown significant promise for the treatment of rare diseases with unmet medical needs. In recent years, however, multiple reports of treatment-related serious adverse events have been reported in several clinical trials. A recent U.S. Food and Drug…